(Reuters) -The U.S. Food and Drug Administration on Friday approved Swiss drugmaker Ferring Pharmaceuticals’ first gene therapy for treating adult patients with a type of bladder cancer. The therapy, Adstiladrin, …
(Reuters) -The U.S. Food and Drug Administration on Friday approved Swiss drugmaker Ferring Pharmaceuticals’ first gene therapy for treating adult patients with a type of bladder cancer. The therapy, Adstiladrin, …